Renaissance Technologies’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
4,186,189
+75,500
| +2% | +$182K | 0.01% | 1052 |
|
|
2025
Q1 | $9.08M | Buy |
4,110,689
+138,500
| +3% | +$306K | 0.01% | 1053 |
|
|
2024
Q4 | $21.6M | Sell |
3,972,189
-166,286
| -4% | -$906K | 0.03% | 637 |
|
|
2024
Q3 | $34.4M | Buy |
4,138,475
+257,034
| +7% | +$2.14M | 0.05% | 450 |
|
|
2024
Q2 | $27.8M | Buy |
3,881,441
+668,552
| +21% | +$4.79M | 0.05% | 470 |
|
|
2024
Q1 | $27.9M | Buy |
3,212,889
+327,200
| +11% | +$2.84M | 0.04% | 496 |
|
|
2023
Q4 | $18.9M | Buy |
2,885,689
+226,000
| +8% | +$1.48M | 0.03% | 637 |
|
|
2023
Q3 | $26.6M | Buy |
2,659,689
+218,514
| +9% | +$2.19M | 0.05% | 454 |
|
|
2023
Q2 | $30.3M | Sell |
2,441,175
-751,325
| -24% | -$9.34M | 0.04% | 487 |
|
|
2023
Q1 | $44.7M | Sell |
3,192,500
-134,448
| -4% | -$1.88M | 0.06% | 385 |
|
|
2022
Q4 | $47.6M | Buy |
3,326,948
+1,804,248
| +118% | +$25.8M | 0.07% | 351 |
|
|
2022
Q3 | $38.9M | Sell |
1,522,700
-352,300
| -19% | -$8.99M | 0.06% | 396 |
|
|
2022
Q2 | $53.3M | Buy |
1,875,000
+961,800
| +105% | +$27.3M | 0.06% | 346 |
|
|
2022
Q1 | $32.2M | Buy |
913,200
+368,400
| +68% | +$13M | 0.04% | 513 |
|
|
2021
Q4 | $22.8M | Sell |
544,800
-405,281
| -43% | -$17M | 0.03% | 641 |
|
|
2021
Q3 | $46.6M | Buy |
950,081
+305,281
| +47% | +$15M | 0.06% | 327 |
|
|
2021
Q2 | $26.9M | Buy |
+644,800
| New | +$26.9M | 0.03% | 584 |
|